OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging therapeutic targets for neuromyelitis optica spectrum disorder
Lukmanee Tradtrantip, Nithi Asavapanumas, A. S. Verkman
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 3, pp. 219-229
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Neuromyelitis Optica Spectrum Disorder
Dean M. Wingerchuk, Claudia F. Lucchinetti
New England Journal of Medicine (2022) Vol. 387, Iss. 7, pp. 631-639
Closed Access | Times Cited: 106

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
Trygve Holmøy, Rune Alexander Høglund, Zsolt Illés, et al.
Journal of Neurology (2020) Vol. 268, Iss. 12, pp. 4522-4536
Open Access | Times Cited: 44

Update on Optic Neuritis: An International View
Simon J. Hickman, Axel Petzold
Neuro-Ophthalmology (2021) Vol. 46, Iss. 1, pp. 1-18
Open Access | Times Cited: 34

Astrocyte‐Derived Exosomes Contribute to Pathologies of Neuromyelitis Optica Spectrum Disorder in Rodent Model
Yi Xie, Bo Chen, Qiong Wang, et al.
Annals of Neurology (2023) Vol. 94, Iss. 1, pp. 163-181
Closed Access | Times Cited: 13

Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics
Kazuo Fujihara, Lawrence J. Cook
Current Opinion in Neurology (2020) Vol. 33, Iss. 3, pp. 300-308
Closed Access | Times Cited: 35

Advances in maintenance therapies for neuromyelitis optica spectrum disorders: a new era of targeted drugs
Yingjie Wang, Yan Xu
Multiple Sclerosis and Related Disorders (2025) Vol. 96, pp. 106351-106351
Closed Access

Current treatment and management of neuromyelitis optica spectrum disorder: areas for improvement
Shima Jahani, Nasim Rezaeimanesh, Mahsa Owji, et al.
Expert Review of Ophthalmology (2025)
Closed Access

Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects
Marta Waliszewska‐Prosół, Justyna Chojdak-Łukasiewicz, Sławomir Budrewićz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2801-2801
Open Access | Times Cited: 25

hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3/ NF-κB signaling in an NMO mouse model
Huiming Xu, Wei Jiang, Xuejia Li, et al.
npj Regenerative Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3

Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation
Wenjing Luo, Huiming Xu, Li Xu, et al.
Glia (2022) Vol. 71, Iss. 2, pp. 284-304
Closed Access | Times Cited: 15

A new form of axonal pathology in a spinal model of neuromyelitis optica
Marina Herwerth, Selin Kenet, Martina Schifferer, et al.
Brain (2022) Vol. 145, Iss. 5, pp. 1726-1742
Open Access | Times Cited: 14

Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis
George Saitakis, Bart K. Chwalisz
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9769-9769
Open Access | Times Cited: 13

Autoimmune encephalitis: novel therapeutic targets at the preclinical level
Josefine Sell, Holger Haselmann, Stefan Hallermann, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 25, Iss. 1, pp. 37-47
Closed Access | Times Cited: 19

Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease
Alexandra B. Kornbluh, Victor M Campano, Claire Har, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 85, pp. 105526-105526
Closed Access | Times Cited: 2

Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis
Haihan Yu, Chuan Qin, Shuo-Qi Zhang, et al.
Journal of Neuroimmunology (2020) Vol. 350, pp. 577449-577449
Closed Access | Times Cited: 18

New Therapeutic Landscape in Neuromyelitis Optica
Madina Tugizova, Luka Vlahovic, Anna Tomczak, et al.
Current Treatment Options in Neurology (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 15

The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders
Wenqun Li, Jiaqin Liu, Wei Tan, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 14, pp. 3059-3065
Open Access | Times Cited: 14

Decipher potential biomarkers of diagnosis and disease activity for NMOSD with AQP4 using LC-MS/MS and Simoa
Jinyang Wang, Jianan Wang, Wei Xie, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109761-109761
Closed Access | Times Cited: 4

Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies
Alessandra Zarantonello, Henrik Pedersen, Nick S. Laursen, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 298-298
Open Access | Times Cited: 10

Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone
Rui Li, Jingqi Wang, Cong Li, et al.
Journal of Neuroimmunology (2021) Vol. 356, pp. 577604-577604
Closed Access | Times Cited: 10

Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond
Simone Mader, Tania Kümpfel, Edgar Meinl
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 427-435
Closed Access | Times Cited: 7

Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder
Katrin Giglhuber, Achim Berthele
Immunotherapy (2020) Vol. 12, Iss. 14, pp. 1053-1066
Closed Access | Times Cited: 10

Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoproteinIgGassociated disorder: A comprehensive neuro‐ophthalmic review
Jaya Sharma, M. Tariq Bhatti, Helen V. Danesh‐Meyer
Clinical and Experimental Ophthalmology (2021) Vol. 49, Iss. 2, pp. 186-202
Closed Access | Times Cited: 9

Prospects of pharmacological regulation of aquaporin function in CNS diseases
Natalia S. Ponamareva, В. Е. Новиков, Elena V. Pozhilova
Reviews on Clinical Pharmacology and Drug Therapy (2023) Vol. 21, Iss. 1, pp. 35-48
Open Access | Times Cited: 2

Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
Atsuki Furube, Tsukasa Kadota, Mina Gochi, et al.
Respiratory Investigation (2022) Vol. 60, Iss. 5, pp. 684-693
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top